Aristolactam BII of saururus chinensis attenuates glutamate-induced neurotoxicity in rat cortical cultures probably by inhibiting nitric oxide production

Planta Medica

Volumn 70, Issue 5, 2004, Pages 391-396

  Kim, So Ra ^a   Sung, Sang Hyun ^b   Kang, So Young ^a   Koo, Kyung Ah ^a   Kim, Seung Hyun ^a   Ma, Choong Je ^a   Lee, Heum Sook ^c   Park, Mi Jung ^c   Kim, Young Choong ^a  

^a Seoul National University   (South Korea)

^b Elcom Science Co Ltd   (South Korea)

^c Seoul National University of Science and Technology   (South Korea)

Author keywords

Aristolactam alkaloid; Glutamate induced toxicity; Neuro protection; Nitric oxide production; Saururaceae; Saururus chinensis

Indexed keywords

ALKALOID; ARISTOLACTAM A2; ARISTOLACTAM B2; ARISTOLOLACTAM; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; PEROXIDE; SAUROLACTAM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATTENUATION; BRAIN CELL; BRAIN CORTEX; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; FETUS; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; SAURURACEAE; SAURURUS CHINENSIS; TISSUE CULTURE;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; LACTAMS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITRIC OXIDE; PHYTOTHERAPY; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SAURURACEAE;

ANIMALIA; SAURURACEAE; SAURURUS CHINENSIS;

EID: 2642535230     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818964     Document Type: Article

References (21)

1. Albright TD, Jessell TM, Kandel ER, Poster MI. Neural science: a century of progress and the mysteries that remain. Cell 2000; 18 (Suppl. 100): 1-55
2. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-4
3. Miyamoto M, Murphy TH, Schnaar RL, Coyle JT. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 1989; 250: 1132-40
4. Aarts MM, Tymianski M. Novel treatment of excitotoxicity: targeted disruption of intra-cellular signalling from glutamate receptors. Biochem Pharmacol 2003; 66: 877-86
5. Michaelis ML. Drugs targeting Alzheimer's disease: some things old and some things new. J Pharmacol Exp Ther 2003; 304: 897-904
6. Trist DG. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications. Pharm Acta Helv 2000; 74: 221-9
7. 3 protect cultured rat cortical cells from glutamate-induced neurodegeneration. J Neurosci Res 1998; 53: 426-32
8. Sung SH, Kim YC. Hepatoprotective diastereomeric lignans from Saururus chinensis Herbs. J Nat Prod 2000; 63: 1019-21
9. Crohare R, Priestap HA, Farina M, Cedola M, Ruveda EA. Aristolactams of Aristolochia argentina. Phytochemistry 1962; 13: 1957-60
10. Priestap HA. Seven aristolactams from Aristolochia argentina. Phytochemstry 1985; 24: 849-52
11. Jang YP, Kim SR, Choi YH, Kim J, Kim SG, Markelonis GJ, Oh TH, Kim YC. Arctigenin protects glutamate-induced neurodegeneration by inhibition of binding to kainate receptor. J Neurosci Res 2002; 68: 233-40
12. Dawson VL, Brahbhatt HP, Mong JA, Dawson TM. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 1994; 33: 1425-30
13. Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50
14. Almeida A, Heales SJR, Bolanos JP, Medina JM. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutamate depletion. Brain Res 1998; 790: 209-16
15. Wink M. Interference of alkaloids with neuroreceptors and ion channels. In: Atta-ur-Tahman, editor. Studies in Natural Products Chemistry, Vol. 21, Bioactive Natural Products (Part B) Amsterdam: Elselvier, 2000: pp 3-122
16. (a) Kim SK, Ryu SY, No J, Choi SU, Kim YS. Cytotoxic alkaloids from Houttuynia cordata. Arch Pharm Res 2001; 24: 518-21;
17. (b) Sun NJ, Antoun M, Chang CJ, Cassady JM. New cytotoxic aristolactams for Pararistolochia flos-avis. J Nat Prod 1987; 50: 843-6
18. Prehn JH, Lippert K, Krieglstein J. Are NMDA or AMPA/kainite receptor antagonists more efficacious in the delayed treatment of excitotoxic neuronal injury? Eur J Pharmacol 1995; 292: 179-89
19. + channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J Neurosci 1996; 16: 5004-13
20. Klatt P, Schmidt K, Brunner F, Mayer B. Inhibitors of brain nitric oxide synthase. J Biol Chem 1994; 269: 1674-80
21. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-29